SEARCH

SEARCH BY CITATION

Additional Supporting Information may be found in the online version of this article.

FilenameFormatSizeDescription
hep26506-sup-0001-supptable.doc232K

Supporting Table S1: IL28B genotype with Clinical, Laboratory and Histological Characteristics, NIH (246) and HALT-C (1237) Cohorts Separately

Table S2: Clinical, Laboratory and Histological Characteristics of the Longitudinal Cohort at Baseline.

Table S3. Clinical, Laboratory and Histological Characteristics of the Longitudinal Cohort at Baseline by IL28B (NIH and HALT-C combined)

hep26506-sup-0002-suppfig1.tif3987KSupplementary figure 1: Frequency of IL28b genotypes by HCV viral genotype (Cross-sectional analysis): 1483 patients were included in the cross-sectional analysis.
hep26506-sup-0003-suppfig2.tif2457KSupplementary figure 2: Change in Ishak fibrosis score between paired biopsies by IL28b genotypes (longitudinal analysis): 276 patients were included in the longitudinal analysis.
hep26506-sup-0004-suppfig3.tif2352KSupplementary figure 3: Change in HAI score between the paired biopsies by IL28b genotypes (longitudinal analysis): 276 patients were included in the longitudinal analysis.
hep26506-sup-0005-suppfig4.tif2241KSupplementary figure 4: Change in ALT levels between the paired biopsies by IL28b genotypes (longitudinal analysis): 276 patients were included in the longitudinal analysis.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.